Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 182 participants.
Also called NCT02586415
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 182 participants
- Sponsor
- Registry
-
NCT02586415
-
- Other papers using this trial's data
- Association of Thrombectomy With Stroke Outcomes Among Patient Subgroups: Secondary Analyses of the DEFUSE 3 Randomized Clinical Trial
- Clinical Outcomes and Identification of Patients With Persistent Penumbral Profiles Beyond 24 Hours From Last Known Well: Analysis From DEFUSE 3
- Endovascular Treatment in the DEFUSE 3 Study
- Ischemic Core and Hypoperfusion Volumes Correlate With Infarct Size 24 Hours After Randomization in DEFUSE 3
- Quality of Life in Physical, Social, and Cognitive Domains Improves With Endovascular Therapy in the DEFUSE 3 Trial
- Rapid Neurologic Improvement Predicts Favorable Outcome 90 Days After Thrombectomy in the DEFUSE 3 Study
- Renal Safety of Multimodal Brain Imaging Followed by Endovascular Therapy
- Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
- What predicts poor outcome after successful thrombectomy in late time windows?
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT02586415. Randomized; no masking; primary purpose treatment. Start 2016-04 (registry gives no type); primary completion 2017-08-23 (actual). Results posted on 2018-09-19.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 3
- Acronym
- DEFUSE 3
- Condition
- Stroke, Acute
- Condition
- Cerebral Infarction
- Intervention (Procedure)
- Endovascular Thrombectomy
- Intervention (Device)
- Trevo Retriever
- Intervention (Device)
- Solitaire™ FR Revascularization Device
- Intervention (Device)
- Penumbra thrombectomy system
- Intervention (Device)
- Covidien MindFrame Capture Revascularization Device
- Lead sponsor
- Gregory W Albers
- Collaborator
- National Institute of Neurological Disorders and Stroke (NINDS)
- Collaborator
- University of Cincinnati
- Collaborator
- Medical University of South Carolina
- Collaborator
- NINDS Stroke Trials Network (StrokeNet)
Record details
- Record id
cardio:ct-nct02586415- Content hash
59984628c64d008ab9cef0edb4af66824b8cdfa576f2fa2612e4c40ae39b4abb